Irbesartan Drug recalled over foreign material
- Recall date
- March 17, 2020
- Source
- U.S. Food & Drug Administration (FDA) — recall announcement
- Official notice title
- Aurobindo Pharma Limited recalls Aurobindo Pharma Limited — Irbesartan Drug
- Brand / firm
- Aurobindo Pharma Limited, Aurobindo Pharma Limited
Why it was recalled
Due to detection of NDEA (N-Nitrosodiethylamine) Impurity — Potential Foreign Material
What was recalled
Irbesartan Drug
Read the official recall notice →
Get recall alerts
Free email alert whenever Aurobindo Pharma Limited has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Aurobindo Pharma Limited, Aurobindo Pharma Limited